☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Opiant Reports the Completion of Patient Enrolment in P-II Study for OPNT002 to Treat Alcohol Use Disorder
October 7, 2022
PharmaShots Weekly Snapshots (October 03 - 07, 2022)
October 7, 2022
Alnylam Reports the US FDA’s Acceptance of sNDA Application Filed for Oxlumo to Treat Advanced Primary Hyperoxaluria
October 7, 2022
6th Annual Medical Device Regulatory and Quality Summit 2022
October 7, 2022
Merck and Ridgeback Report Results for Lagevrio in P-II Studies for the Treatment of COVID-19
October 7, 2022
Abbott Reports New (FLASH-UK) Trial Results of FreeStyle Libre 2 System for Type 1 Diabetes and Sub-Optimal Glycemic Control
October 7, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions